Philadelphia University + Thomas Jefferson University

News & Events

<< Back to News & Events List

JCBS Researchers & Students: Fighting Against Ebola

10/06/14

In recent months, the Ebola epidemic in West Africa has become the focus of the world's attention and researchers at Thomas Jefferson University, led by Dr. Matthias Schnell, are working on an Ebola vaccine housed within a rabies vaccine, potentially protecting individuals from both diseases.

Ebola Strands

Photo Credit: NIH NIAID DIR RTB

Ben Davis, JGSBS PhD candidate

Ben Davis, JCBS PhD candidate in the Immunology & Microbial Pathogenesis program, looks for changes in the gene signature of tissue infected with rabies virus in order to find clues for more effective vaccines.

Drishya Kurup and Matthias Schnell

Drishya Kurup and Matthias Schnell inspect Vero cells in tissue culture flasks. Tissue culture cells provide a fertile ground for the growth of modified strains of virus that could lead to novel strategies for controlling the spread of Ebola.

Drishya Kurup, graduate of JGSBS MS Microbiology

Drishya Kurup, graduate of JCBS MS Microbiology program, works in a sterile tissue culture hood. The machine to her right is used to concentrate virus grown in the lab to the right levels for injection into animals.

Dr. Matthias Schnell

Dr. Matthais Schnell works in a sterile tissue culture hood. The machine to his right is used to concentrate virus grown in the lab to the right levels for injection into animals.

Rohan Keshwara, JGSBS PhD candidate

Rohan Keshwara, JCBS PhD candidate in the Immunology & Microbial Pathogenesis program,  inspects Vero cells in tissue culture flasks. Tissue culture cells provide a fertile ground for the growth of modified strains of virus that could lead to novel strategies for controlling the spread of Ebola.

Articles & Links